Showing results (91-100 of 121) with videos related to

Sort By:
Pageof 13
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|September 7, 2011
Risk factors for postendoscopic retrograde cholangiopancreatography pancreatitis: a retrospective analysis of 7,168 casesWence Zhou, Yumin Li, Quanbao Zhang, et al.
Human Cell|September 24, 2022
Establishment and characterization of a new Chinese hepatocellular carcinoma cell line, Hep-X1Hao Xu, Xin Miao, Changpeng Chai, et al.
Human Cell|January 20, 2023
Establishment and characterization of a new intrahepatic cholangiocarcinoma cell line, ICC-X3Hao Xu, Wei Luo, Zhenjie Zhao, et al.
Journal of Nanobiotechnology|February 24, 2026
Targeting redox metabolism and low-dose radiotherapy synergistically activate cGAS-STING pathway to improve NK cell therapy efficacy in hepatocellular carcinomaBo Liu, Wenjia Kong, Xijie Zhang, et al.
Molecular Biology Reports|July 30, 2011
Cyclooxygenase-2 -765 G/C polymorphisms and susceptibility to hepatitis B-related liver cancer in Han Chinese populationJianhong He, Quanbao Zhang, Zhijian Ren, et al.
Frontiers in Molecular Biosciences|December 18, 2023
A risk signature based on endoplasmic reticulum stress-associated genes predicts prognosis and immunity in pancreatic cancerHaofei Chen, Ning Xu, Jia Xu, et al.
Journal of Clinical Medicine|October 14, 2022
Laparoscopic versus Robotic Hepatectomy: A Systematic Review and Meta-AnalysisTaslim Aboudou, Meixuan Li, Zeliang Zhang, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 30, 2025
Enzyme-powered micellar nanoreactors enable tumor-specific, cascade-amplified prodrug activation for synergistic oxidation-chemo-immunotherapyXin Li, Lili Sun, Xianling Liu, et al.
Plos One|March 4, 2014
Silencing alpha-fetoprotein inhibits VEGF and MMP-2/9 production in human hepatocellular carcinoma cellWenbo Meng, Xun Li, Zhongtian Bai, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 20, 2025
Proton-Pump Inhibitor Use and Gastrointestinal Disease Risk: A Mendelian Randomization Study of Omics and Pharmacological PathwaysWeixiong Zhu, Chuanlei Fan, Hongyu Wang, et al.
Pageof 13